Welcome to Rheumatology / Arthritis & Autoimmune Diseases Research Center (AADRC)
The section of Rheumatology and the Clinical Epidemiology Research and Training Unit, both sections within the Department of Medicine, have been merged, combining the faculty and resources of both sections. Dr. Tuhina Neogi, Professor of Medicine and Epidemiology, is the Chief of Rheumatology. Within this merged section also sits the Arthritis & Autoimmune Diseases Research Center (AADRC), which focuses on rheumatic disease research.
Faculty members have research interests focusing on different areas of rheumatic diseases and methodology. Clinical and research expertise within the section includes scleroderma, gout, osteoarthritis, spondyloarthritis, lupus, and other forms of inflammatory arthritis and autoimmune diseases. Many of the faculty are national and international leaders in their respective fields, with several faculty leading national treatment guideline efforts and other research and clinical endeavors. The Rheumatology Fellowship Training Program is nationally recognized for its clinical and research training, including musculoskeletal ultrasound training.
The AADRC is an internationally recognized center in research, patient care and education, established in 1983 to advance basic, clinical, and epidemiological research in rheumatology and to translate laboratory findings into new therapeutic strategies. The AADRC has made substantial contributions to scleroderma research. The clinical research program is internationally recognized for advanced and novel methodology. Additional research foci beyond rheumatology-related diseases include fibrosis, physical therapy, mobile health technologies, imaging (MRI and musculoskeletal ultrasound), and musculoskeletal pain. The section’s research teams have been at the forefront of developing new approaches to study and test new treatments for scleroderma, osteoarthritis, lupus and other autoimmune disorders.
Clinical care is provided at the Boston Medical Center Rheumatology Clinic in state-of-the art facilities.
Tuhina Neogi, MD, PhD, FRCPC
Section Chief, Rheumatology